SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sequenom, Inc. (SQNM)
An SI Board Since January 2000
Posts SubjectMarks Bans Symbol
364 54 0 SQNM
Emcee:  Nav Toor Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
314 Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Savant-2/27/2014
313 Sequenom And Laboratoire Cerba Announce Commercial Launch Of Cerba&#Savant-12/5/2013
312SAN DIEGO, Dec. 3, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a Savant-12/5/2013
311 Sequenom CMM's MaterniT21 PLUS testing service received clinicalSavant-8/7/2013
310Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2013 ContinueSavant-7/25/2013
309Sequenom, Inc. Announces Date Of Second Quarter 2013 Financial Results And ConfeSavant-7/10/2013
308Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and ConferSavant-4/25/2013
307Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year OfSavant-3/9/2013
306Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific ChromosoSavant-2/4/2013
305Sequenom Announces Preliminary 2012 Operational Highlights SAN DIEGO, Jan. 6, Savant-1/30/2013
304Sequenom Announces Participation At 31st Annual JP Morgan Healthcare Conference Savant-1/3/2013
303Dec 17th Sequenom provided update, late Friday night, on status of patent for meSavant-1/3/2013
302I don't give the ACTC program much chance of succeeding. DewDiligence_on_SI-11/13/2012
301You mean...yet. ACTC, for one, is working on a stem cell treatment for wet anSavant-11/13/2012
300I question the commercial value of this diagnostic: siliconinvestor.com CommentDewDiligence_on_SI-11/13/2012
299Study Shows Sequenom CMM's RetnaGene LDT Accurately Predicts Risk of ProgresSavant-11/13/2012
298Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2012 And AnnoSavant-11/13/2012
297Sequenom Announces Participation At Two Upcoming Investor Conferences SAN DIEGSavant-11/6/2012
296Sequenom, Inc. Announces Date Of Third Quarter 2012 Financial Results And ConfeSavant-10/18/2012
295Article today on SA regarding short interest of SQNM. Short interest at over 28%Steve Lokness-9/20/2012
294Nice recovery off that dump earlier. Clocked about 800K that hit the bid. No ideLawrence Burg-9/18/2012
293*And we get big, fat, juicey raises...G&A..lol. [Text Chart]Savant-9/17/2012
292Likely the selling was some traders taking their 10% profit from their buying onSavant-9/17/2012
291Pretty surprising price. And the recovery, also. I'm wondering about the beLawrence Burg-9/17/2012
290Priced... Sequenom Prices Offering of $110 Million of its 5.00% Convertible SeniSavant-9/12/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News